These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9549756)

  • 1. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications.
    Yabe-Nishimura C
    Pharmacol Rev; 1998 Mar; 50(1):21-33. PubMed ID: 9549756
    [No Abstract]   [Full Text] [Related]  

  • 2. Aldose reductase and its inhibition in the control of diabetic complications.
    Narayanan S
    Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldose reductase inhibitors and diabetic kidney disease.
    Oates PJ
    Curr Opin Investig Drugs; 2010 Apr; 11(4):402-17. PubMed ID: 20336588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of aldose reductase inhibitors in diabetic complications: recent trends.
    Kaul CL; Ramarao P
    Methods Find Exp Clin Pharmacol; 2001 Oct; 23(8):465-75. PubMed ID: 11838322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aldose reductase inhibitors].
    Yoneta T; Tagashira E
    Nihon Rinsho; 1991 Sep; 49(9):2017-23. PubMed ID: 1960870
    [No Abstract]   [Full Text] [Related]  

  • 6. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.
    El-Kabbani O; Wilson DK; Petrash M; Quiocho FA
    Mol Vis; 1998 Sep; 4():19. PubMed ID: 9756955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic cataracts and flavonoids.
    Varma SD; Mizuno A; Kinoshita JH
    Science; 1977 Jan; 195(4274):205-6. PubMed ID: 401544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of aldose reductase by nonenzymatic glycosylation.
    Srivastava SK; Ansari NH; Bhatnagar A; Hair G; Liu S; Das B
    Prog Clin Biol Res; 1989; 304():171-84. PubMed ID: 2506561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the polyol pathway in diabetes mellitus.
    Collier A; Small M
    Br J Hosp Med; 1991 Jan; 45(1):38-40. PubMed ID: 1901236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of chronic complications of diabetes mellitus with aldose reductase inhibitors].
    Cattalini M; Lerario AC
    Rev Assoc Med Bras (1992); 1996; 42(2):109-14. PubMed ID: 9110460
    [No Abstract]   [Full Text] [Related]  

  • 11. Aldose reductase inhibitors.
    Kirchain WR; Rendell MS
    Pharmacotherapy; 1990; 10(5):326-36. PubMed ID: 2122421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discoveries in research on diabetic keratopathy.
    Cisarik-Fredenburg P
    Optometry; 2001 Nov; 72(11):691-704. PubMed ID: 12363257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All in the family: aldose reductase and closely related aldo-keto reductases.
    Petrash JM
    Cell Mol Life Sci; 2004 Apr; 61(7-8):737-49. PubMed ID: 15094999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monkey 3-deoxyglucosone reductase: tissue distribution and purification of three multiple forms of the kidney enzyme that are identical with dihydrodiol dehydrogenase, aldehyde reductase, and aldose reductase.
    Sato K; Inazu A; Yamaguchi S; Nakayama T; Deyashiki Y; Sawada H; Hara A
    Arch Biochem Biophys; 1993 Dec; 307(2):286-94. PubMed ID: 8274014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate specificity of reduced and oxidized forms of human aldose reductase.
    Vander Jagt DL; Hunsaker LA
    Adv Exp Med Biol; 1993; 328():279-88. PubMed ID: 8493905
    [No Abstract]   [Full Text] [Related]  

  • 16. Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications.
    Giannoukakis N
    Expert Opin Investig Drugs; 2008 Apr; 17(4):575-81. PubMed ID: 18363521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
    Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
    Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy: Promises and Challenges.
    ElGamal H; Munusamy S
    Protein Pept Lett; 2017; 24(1):71-77. PubMed ID: 27894247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldose reductase inhibitors and nanodelivery of diabetic therapeutics.
    Prior AM; Thapa M; Hua DH
    Mini Rev Med Chem; 2012 Apr; 12(4):326-36. PubMed ID: 22303947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progress in aldose reductase].
    Gu J; Yan J; Wu W; Huang Q; Ouyang D
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 35(4):395-400. PubMed ID: 20448367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.